Display options
Cite
Cherny NI, Portenoy RK, Raber M, et al. Medikamentöse Therapie von Tumorschmerzen : II. Anwendung von Opioiden. [Pharmacotherapy of cancer pain : 2. Use of opioids.]. Schmerz. 1995;9(1):3-19doi: 10.1007/BF02530380.
Cherny, N. I., Portenoy, R. K., Raber, M., & Zenz, M. (1995). Medikamentöse Therapie von Tumorschmerzen : II. Anwendung von Opioiden. [Pharmacotherapy of cancer pain : 2. Use of opioids.]. Schmerz (Berlin, Germany), 9(1), 3-19. https://doi.org/10.1007/BF02530380
Cherny, N I, et al. "Medikamentöse Therapie von Tumorschmerzen : II. Anwendung von Opioiden." [Pharmacotherapy of cancer pain : 2. Use of opioids.]. Schmerz (Berlin, Germany) vol. 9,1 (1995): 3-19. doi: https://doi.org/10.1007/BF02530380
Cherny NI, Portenoy RK, Raber M, Zenz M. Medikamentöse Therapie von Tumorschmerzen : II. Anwendung von Opioiden. [Pharmacotherapy of cancer pain : 2. Use of opioids.]. Schmerz. 1995 Jan;9(1):3-19. doi: 10.1007/BF02530380. German. PMID: 18415494.
Copy Download .nbib Format: NLM
Share it on

Schmerz. 1995 Jan;9(1):3-19. doi: 10.1007/BF02530380.

[Pharmacotherapy of cancer pain : 2. Use of opioids.].

Schmerz (Berlin, Germany)

[Article in German]
N I Cherny, R K Portenoy, M Raber, M Zenz

Affiliations

  1. Department Internal Medicine and Medical Oncology, Shaare-Zedek Medical Center, 91031, Jerusalem, Israel.

PMID: 18415494 DOI: 10.1007/BF02530380

Abstract

The adequate use of opioids in the treatment of chronic cancer pain requires sound knowledge of selection criteria for the various opioids, the routes of administration, dosages, dosing schemes and possible side effects. Drug selection depends on the intensity of pain rather than on the specific pathophysiology. Mild to moderate pain can often be treated effectively by so-called "weak" opioids. These include codeine, dihydrocodeine and dextropropoxyphene. Non-opioid analgesics, like acetylsalicylic acid or paracetamol can be added according to the "analgesic ladder" proposed by the World Health Organization (WHO). If adequate pain relief is not achieved "strong" opioids are required. The route of administration that is the safest and the least invasive for the patient should be chosen. Non-invasive (oral, rectal, sublingual, transdermal and intranasal) and invasive routes (intravenous, subcutaneous, spinal and epidural) are available (Table 8). Noninvasive routes are preferred, and most patients can be maintained on oral opioids. Alternatively, in some patients pain can be managed by the sublingual (buprenorphine) route. A transdermal preparation exists for fentanyl, but has not yet been approved for the German market. If the oral route cannot be used or if large doses are required, it will be necessary to change to an invasive route. Intravenous bolus injections provide the fastest onset of analgesic action. They are mostly used in very severe pain. Repeated injections can be avoided by using intravenous or subcutaneous infusions. Various types of pumps delivering analgesics at constant basal infusion rates with the option of rescue doses in case of breakthrough pain are available (patient-controlled analgesia=PCA). Opioids frequently used for s. c. infusion are morphine and hydromorphone. Adjuvant drugs (antiemetics, anxiolytics) can be added. Epidural or intrathecal administration of opioids should only be used in intractable pain or if severe side effects, such as sedation and confusion, will arise with systemic opioids. Morphine, hydromorphone, fentanyl and sufentanil have been used, as have other additional compounds (e.g. local anaesthetics, clonidine). Intracerebroventricular application of morphine has been used only occasionally. In all cases, opioids should be given on to a fixed time schedule thereby, preventing pain from recurring. Additional rescue doses (approximately 50% of baseline single dose) are given for break-through pain. The most frequent side effect of opioids is constipation, and the administration of laxatives is often recommended (Table 5). Nausea, vomiting, sedation and confusion mostly occur in the beginning of opioid therapy. In contrast to constipation, tolerance to these effects develops within days or weeks. True dependence or psychological addiction rarely occurs in patients with chronic cancer pain. In most cases, progression of the underlying disease associated with increasing tissue damage and increasing pain is found. Fear of dependence and addiction often contributes to undertreatment of patients suffering from chronic cancer pain.

References

  1. Ann Emerg Med. 1986 May;15(5):566-70 - PubMed
  2. Anesthesiology. 1989 Jun;70(6):928-34 - PubMed
  3. Clin Pharmacol Ther. 1990 May;47(5):565-77 - PubMed
  4. Anesthesiology. 1981 Jun;54(6):451-67 - PubMed
  5. Lancet. 1985 Jul 27;2(8448):211 - PubMed
  6. Cancer. 1989 Jun 1;63(11 Suppl):2308-20 - PubMed
  7. Cancer. 1988 Jul 15;62(2):407-11 - PubMed
  8. Clin J Pain. 1990 Mar;6(1):57-9 - PubMed
  9. J Pain Symptom Manage. 1990 Apr;5(2):83-93 - PubMed
  10. Clin Pharmacol Ther. 1988 Sep;44(3):335-42 - PubMed
  11. Clin Pediatr (Phila). 1990 Jan;29(1):44-8 - PubMed
  12. Br J Clin Pharmacol. 1982 May;13(5):665-73 - PubMed
  13. J Pharmacol Exp Ther. 1985 Jan;232(1):149-55 - PubMed
  14. Drug Intell Clin Pharm. 1987 Oct;21(10):773-83 - PubMed
  15. Dtsch Med Wochenschr. 1985 Mar 22;110(12):448-53 - PubMed
  16. Cancer. 1989 Apr 15;63(8):1636-44 - PubMed
  17. J Clin Oncol. 1989 Dec;7(12):1903-8 - PubMed
  18. Can J Anaesth. 1989 Sep;36(5):491-3 - PubMed
  19. Pain. 1987 Jan;28(1):61-68 - PubMed
  20. J Clin Gastroenterol. 1989 Apr;11(2):132-5 - PubMed
  21. Pain. 1989 Oct;39(1):13-16 - PubMed
  22. Pain. 1990 Dec;43(3):273-286 - PubMed
  23. N Engl J Med. 1985 Jul 11;313(2):84-95 - PubMed
  24. J Pain Symptom Manage. 1989 Mar;4(1):3-6 - PubMed
  25. Schmerz. 1993 Dec;7(4):314-21 - PubMed
  26. Acta Anaesthesiol Scand Suppl. 1987;85:68-74 - PubMed
  27. Gastroenterology. 1988 Jun;94(6):1351-6 - PubMed
  28. J Pharmacol Exp Ther. 1982 Oct;223(1):203-6 - PubMed
  29. Pain. 1988 Apr;33(1):11-23 - PubMed
  30. Pain. 1990 Oct;43(1):47-55 - PubMed
  31. Pain. 1990 Jun;41(3):273-281 - PubMed
  32. Clin Pharmacol Ther. 1980 Dec;28(6):823-6 - PubMed
  33. Lancet. 1984 Nov 24;2(8413):1208-9 - PubMed
  34. J Pain Symptom Manage. 1990 Feb;5(1):33-41 - PubMed
  35. Pain. 1991 Apr;45(1):11-15 - PubMed
  36. Pain. 1990 Nov;43(2):155-162 - PubMed
  37. Ann Intern Med. 1983 Dec;99(6):870-3 - PubMed
  38. Pain. 1981 Dec;11(3):293-346 - PubMed
  39. Schmerz. 1990 Mar;4(1):14-21 - PubMed
  40. Anaesthesia. 1993 Sep;48(9):753-7 - PubMed
  41. J Clin Pharmacol. 1977 May-Jun;17(5-6):276-91 - PubMed
  42. Clin Pharmacol Ther. 1981 Nov;30(5):629-35 - PubMed
  43. Pain. 1989 Apr;37(1):97-101 - PubMed
  44. Acta Anaesthesiol Scand. 1988 Apr;32(3):253-9 - PubMed
  45. J Pain Symptom Manage. 1991 Jul;6(5):329-36 - PubMed
  46. Cancer. 1991 Feb 15;67(4):873-82 - PubMed
  47. World Health Organ Tech Rep Ser. 1990;804:1-75 - PubMed
  48. Pain. 1992 Apr;49(1):87-91 - PubMed
  49. Anesthesiology. 1988 Sep;69(3):428-32 - PubMed
  50. Am J Psychiatry. 1987 Aug;144(8):1062-5 - PubMed
  51. Clin Obstet Gynecol. 1987 Sep;30(3):552-65 - PubMed
  52. Anesthesiology. 1988 Jun;68(6):929-33 - PubMed
  53. Pain. 1991 May;45(2):149-153 - PubMed
  54. Lancet. 1991 Feb 23;337(8739):465-8 - PubMed
  55. Anesth Analg. 1993 May;76(5):1047-51 - PubMed
  56. Br J Clin Pharmacol. 1989 Feb;27(2):147-57 - PubMed
  57. J Pain Symptom Manage. 1991 Apr;6(3):125-8 - PubMed
  58. Pain. 1991 May;45(2):141-143 - PubMed
  59. Life Sci. 1985 Sep 23;37(12):1137-44 - PubMed
  60. Drug Intell Clin Pharm. 1981 Dec;15(12):945-50 - PubMed
  61. Clin Pharmacol Ther. 1988 Oct;44(4):376-82 - PubMed
  62. Med Clin North Am. 1987 Mar;71(2):233-41 - PubMed
  63. J Pain Symptom Manage. 1990 Dec;5(6):362-7 - PubMed
  64. N Engl J Med. 1977 Mar 31;296(13):712-5 - PubMed
  65. Ann N Y Acad Sci. 1981;362:161-72 - PubMed
  66. Pain. 1990 Oct;43(1):91-94 - PubMed
  67. J Pain Symptom Manage. 1991 Oct;6(7):428-30 - PubMed
  68. Med Clin North Am. 1987 Mar;71(2):207-32 - PubMed
  69. Arch Intern Med. 1990 Sep;150(9):1897-903 - PubMed
  70. Arch Intern Med. 1986 Apr;146(4):734-6 - PubMed
  71. Pain. 1989 Dec;39(3):297-300 - PubMed
  72. Br Med J (Clin Res Ed). 1986 Jun 14;292(6535):1548-9 - PubMed
  73. Clin Pharm. 1984 Nov-Dec;3(6):585-6 - PubMed
  74. N Engl J Med. 1980 Jan 10;302(2):123 - PubMed
  75. Lancet. 1993 Apr 24;341(8852):1075-6 - PubMed
  76. Clin Pharmacol Ther. 1985 Dec;38(6):631-41 - PubMed
  77. Clin Pharmacol Ther. 1990 Sep;48(3):236-44 - PubMed
  78. Br J Clin Pharmacol. 1990 Mar;29(3):289-97 - PubMed
  79. Br Med J (Clin Res Ed). 1987 Feb 28;294(6571):553-5 - PubMed
  80. Cancer. 1989 Jun 1;63(11 Suppl):2257-65 - PubMed
  81. Anesth Analg. 1989 Jun;68(6):710-1 - PubMed
  82. Schmerz. 1988 Dec;2(4):183-97 - PubMed
  83. Anaesthesist. 1993 May;42(5):309-15 - PubMed
  84. Schmerz. 1994 Jun;8(2):71-81 - PubMed
  85. Oncol Nurs Forum. 1986 Jul-Aug;13(4):53-7 - PubMed
  86. Heart Lung. 1988 Sep;17(5):495-8 - PubMed
  87. J Natl Cancer Inst. 1988 Sep 21;80(14):1152-4 - PubMed
  88. Br J Anaesth. 1988 May;60(6):608-13 - PubMed
  89. Cancer Treat Rep. 1987 Jan;71(1):67-70 - PubMed
  90. Pain. 1990 Jan;40(1):21-28 - PubMed
  91. Lancet. 1991 Jun 15;337(8755):1475 - PubMed
  92. Pain. 1989 Apr;37(1):15-21 - PubMed
  93. Clin Pharmacol Ther. 1991 Apr;49(4):442-8 - PubMed
  94. Ann Intern Med. 1988 Apr;108(4):554-7 - PubMed
  95. J Pharmacol Exp Ther. 1978 Oct;207(1):92-100 - PubMed
  96. Anesth Analg. 1989 Jul;69(1):21-7 - PubMed
  97. Anaesthesia. 1981 Jan;36(1):37-9 - PubMed
  98. Anesthesiology. 1985 Mar;62(3):358-63 - PubMed
  99. Pain. 1991 Mar;44(3):215-220 - PubMed

Publication Types